Cornerstone Capital Management Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-111,980	Closed	-$6.63M	–	1381
2016 Q4	$6.63M	Buy	111,980 +20,700	+23%	+$1.28M	0.05%	390
2016 Q3	$6.05M	Buy	91,280 +23,739	+35%	+$1.47M	0.04%	422
2016 Q2	$3.65M	Buy	67,541 +9,508	+16%	+$521K	0.03%	539
2016 Q1	$3M	Sell	58,033 -18,500	-24%	-$961K	0.03%	613
2015 Q4	$5.37M	Sell	76,533 -29,346	-28%	-$2M	0.04%	437
2015 Q3	$6.59M	Buy	105,879 +10,200	+11%	+$804K	0.06%	351
2015 Q2	$8.04M	Sell	95,679 -9,000	-9%	-$700K	0.07%	326
2015 Q1	$7.87M	Buy	104,679 +1,800	+2%	+$126K	0.07%	329
2014 Q4	$6.39M	Sell	102,879 -13,200	-11%	-$753K	0.07%	369
2014 Q3	$6.04M	Buy	+116,079	New	+$5.92M	0.07%	370

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Cornerstone Capital Management Holdings's XBI Position: Q1 2017 in Review

Cornerstone Capital Management Holdings sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2017, closing a stake of 111,980 shares — an estimated $6.63M sold.

Cornerstone Capital Management Holdings first reported a position in XBI in Q3 2014 and held it in 10 quarters. The position peaked at $8.04M in Q2 2015. 292 funds tracked by Wall St. Rank hold XBI as of Q1 2017.

Cornerstone Capital Management Holdings reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2017 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 111,980 State Street SPDR S&P Biotech ETF shares in Q1 2017, an estimated $6.63M.
Cornerstone Capital Management Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q3 2014 and held it in 10 quarters.
Cornerstone Capital Management Holdings's State Street SPDR S&P Biotech ETF position peaked at $8.04M in Q2 2015.
292 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2017, filed 10 May 2017.